First Generic Version of Chantix Now Available
Par’s generic version of Chantix is currently the only available one in the US.
Smoking
Pfizer Expands Recall to All Lots of Chantix Due to Nitrosamine Impurity
The recalled lots of Chantix were distributed nationwide to wholesalers and distributors in the United States and Puerto Rico from May 2019 to September 2021.
FDA Bans Sale of Nearly a Million E-Cigarettes
However, Juul products will remain on the market for now
FDA Issues Marketing Denial Orders for Flavored E-Cigarette Products
The MDOs were issued to approximately 55,000 flavored ENDS products from JD Nova Group LLC, Great American Vapes, and Vapor Salon and included favors such as Apple Crumble, Dr. Cola and Cinnamon Toast Cereal.
Half of Youth E-Cigarette Users Intend to Quit
Vaping cessation behaviors tied to tobacco co-use, vaping device, harm perceptions, and reasons for vaping
Pfizer Expands Chantix Recall Due to Nitrosamine Impurity
To date, the Company has not received any reports of adverse events related to this recall.
Secondhand Marijuana Smoke Tied to Respiratory Infections in Children
However, no negative impact seen on emergency department or urgent care visits, otitis media episodes, or asthma exacerbations
E-Cigarette Use During Pregnancy Tied to Adverse Birth Outcomes
Low birth weight, preterm delivery seen particularly among individuals using e-cigarettes daily
FDA Takes Steps to Maintain Supply of Smoking Cessation Therapy
N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.
Cytisine Not Noninferior to Varenicline for Smoking Cessation
Significantly fewer adverse reactions reported by those in the cytisine group versus the varenicline group.
